EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comparison of Safety and Efficacy of Cefepime Administered via Intravenous Push Versus Intravenous Piggyback Infusion in Patients with Gram-Negative Bacteremia

Mary Fronrath, Carolyn Martz, Kristin Griebe iD, Michael Veve, Zachary R Smith iD

Journal of Clinical Medicine · 19.06.2026 · 15 (12) · 4768

DOI: 10.3390/jcm15124768 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 19.06.2026. Verfasst von Mary Fronrath und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Henry Ford Hospital, Detroit, MI 48202, USA. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Intravenous push (IVP) beta-lactam antibiotics have been adopted during parenteral solution shortages to conserve resources. Data evaluating the safety and efficacy of cefepime administered IVP versus intravenous piggyback (IVPB) infusion in Gram-negative bacteremia remain limited. We compared clinical outcomes of cefepime administered IVP versus IVPB in hospitalized patients with Gram-negative bacteremia.

Methods

This was a retrospective cohort study across a five-hospital health system from 1 January 2014 through 31 December 2021. Adults receiving cefepime for Gram-negative bacteremia were included. The primary outcome was a tailored desirability of outcome ranking (DOOR) composite assessed through 30 days or hospital discharge, integrating clinical cure and cefepime-associated neurologic adverse effects. Clinical cure was defined as absence of recurrent bacteremia with the index pathogen after 48 h, no antibiotic escalation, and no in-hospital mortality.

Results

A total of 254 met the inclusion criteria (127 IVPB; 127 IVP). Baseline severity was similar between groups. The primary outcome assessed by DOOR revealed no difference between IVPB and IVP groups (p = 0.656). Vasopressor support during therapy was more frequent in the IVP group (22.0% vs. 10.2%, p = 0.011), and median hospital length of stay was longer (10 vs. 7 days, p = 0.020). No differences were noted in other endpoints. General ward admission (OIR [aOR] 2.563, 95% CI 1.271–5.168; p = 0.009) and genitourinary source of bacteremia (aOR 3.398, 95% CI 1.509–7.652; p = 0.003) independently predicted clinical cure.

Conclusions

In patients with Gram-negative bacteremia, cefepime administered IVP demonstrated similar safety and efficacy to IVPB infusion.

Schlagwörter

Stichwörter der Autor:innen

antibacterial agentscefepimecritical illnessdrug administration routessepsis

Autor:innen und Institutionen

  • Department of Pharmacy, Henry Ford Hospital, Detroit, MI 48202, USA.
  • Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI 48202, USA.

ORCID-Profile: Kristin Griebe, Zachary R Smith

Zitieren

APA

Fronrath, M., Martz, C., Griebe, K., Veve, M., & Smith, Z. R. (2026). Comparison of Safety and Efficacy of Cefepime Administered via Intravenous Push Versus Intravenous Piggyback Infusion in Patients with Gram-Negative Bacteremia. Journal of Clinical Medicine, 15(12), 4768. https://doi.org/10.3390/jcm15124768

Vancouver

Fronrath M, Martz C, Griebe K, Veve M, Smith ZR. Comparison of Safety and Efficacy of Cefepime Administered via Intravenous Push Versus Intravenous Piggyback Infusion in Patients with Gram-Negative Bacteremia. Journal of Clinical Medicine. 2026;15(12):4768. doi:10.3390/jcm15124768

BibTeX
@article{Fronrath2026,
  author = {Fronrath, Mary and Martz, Carolyn and Griebe, Kristin and Veve, Michael and Smith, Zachary R},
  title = {Comparison of Safety and Efficacy of Cefepime Administered via Intravenous Push Versus Intravenous Piggyback Infusion in Patients with Gram-Negative Bacteremia},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {12},
  pages = {4768},
  doi = {10.3390/jcm15124768}
}
Kostenlos starten →